Floatz logo

Antithrombin Iii

Hemophilia A

Sanofiprotein_peptidePhase 4 / ApprovedActive
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
73/ 100

Competitive context

66 Active assets in the Hemophilia A cohort.

Asset / SponsorPhaseRating
Turoctocog Alfa
Novo Nordisk A/S
Phase 4A
Eptacog Alfa
AryoGen Pharmed Co.
Phase 4A
Rurioctocog Alfa Pegol
Takeda
Phase 4BBB
Turoctocog Alfa Pegol
Novo Nordisk A/S
Phase 3BBB
bay94-9027
Bayer
Phase 4BBB

View all 50 →

Same molecule, other indications

Antithrombin Iii is also rated in:

hemophiliaDormant
B
Indicative ·
57 / 100
View asset →
portal vein thrombosisDormant
CC
Indicative ·
41 / 100
View asset →
cirrhosis of liverDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →